Literature DB >> 1546149

Relationship of anxiety and depression.

A Frances1, D Manning, D Marin, J Kocsis, K McKinney, W Hall, M Kline.   

Abstract

There has been considerable controversy regarding the relationship between depression and anxiety. We review briefly the descriptive, longitudinal, genetic, biological, and treatment response data indicating that there is overlap between depression and anxiety. Several possible models are explored that provide different conceptions of how this relationship may best be understood: (1) that there are a variety of more or less discrete, but sometimes coexisting, syndromes within the spectrum of anxiety and depression; (2) that symptoms of depression and anxiety represent different external manifestations of a more basic underlying cause; (3) that one condition may predispose to the other; (4) that the association may be due to artifactual definitional overlap, particularly since the instruments used to measure depression and anxiety share so many items. All these propositions are supported. An important, practical question is discussed--should the mixed anxiety/depressive disorder that has been suggested by ICD-10 be included in DSM-IV?

Entities:  

Mesh:

Year:  1992        PMID: 1546149     DOI: 10.1007/bf02246243

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  15 in total

1.  A scaled version of the General Health Questionnaire.

Authors:  D P Goldberg; V F Hillier
Journal:  Psychol Med       Date:  1979-02       Impact factor: 7.723

2.  Depressive symptoms and depressive diagnoses in a community population. Use of a new procedure for analysis of psychiatric classification.

Authors:  D Blazer; M Swartz; M Woodbury; K G Manton; D Hughes; L K George
Journal:  Arch Gen Psychiatry       Date:  1988-12

3.  Panic and generalized anxiety disorders. Developmental antecedents and precipitants.

Authors:  M Raskin; H V Peeke; W Dickman; H Pinsker
Journal:  Arch Gen Psychiatry       Date:  1982-06

4.  Imipramine and chlordiazepoxide in depressive and anxiety disorders. II. Efficacy in anxious outpatients.

Authors:  R J Kahn; D M McNair; R S Lipman; L Covi; K Rickels; R Downing; S Fisher; L M Frankenthaler
Journal:  Arch Gen Psychiatry       Date:  1986-01

Review 5.  Mixed anxiety and depression.

Authors:  W Katon; P P Roy-Byrne
Journal:  J Abnorm Psychol       Date:  1991-08

Review 6.  Tripartite model of anxiety and depression: psychometric evidence and taxonomic implications.

Authors:  L A Clark; D Watson
Journal:  J Abnorm Psychol       Date:  1991-08

7.  The Zurich Study. VI. A continuum from depression to anxiety disorders?

Authors:  J Angst; A Dobler-Mikola
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1985

8.  Neurotic illness and its response to anxiolytic and antidepressant treatment.

Authors:  E C Johnstone; D G Owens; C D Frith; K McPherson; C Dowie; G Riley; A Gold
Journal:  Psychol Med       Date:  1980-05       Impact factor: 7.723

9.  The overlap between depression and anxiety on different levels of psychopathology.

Authors:  W Hiller; M Zaudig; M von Bose
Journal:  J Affect Disord       Date:  1989 Mar-Jun       Impact factor: 4.839

Review 10.  Categorical and unitary classification of neurotic disorder.

Authors:  M Roth
Journal:  J R Soc Med       Date:  1990-10       Impact factor: 18.000

View more
  6 in total

Review 1.  Suicidality and antiepileptic drugs: is there a link?

Authors:  Vladimir V Kalinin
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

2.  Relationship between psychological status and disease activity and quality of life in ankylosing spondylitis.

Authors:  Ozlem Baysal; Bekir Durmuş; Yüksel Ersoy; Zuhal Altay; Kazım Senel; Kemal Nas; Mahir Uğur; Arzu Kaya; Ali Gür; Akın Erdal; Ozge Ardıçoğlu; Ibrahim Tekeoğlu; Remzi Cevik; Kadir Yıldırım; Ayhan Kamanlı; Ayşegül Jale Saraç; Saliha Karatay; Salih Ozgocmen
Journal:  Rheumatol Int       Date:  2010-03-10       Impact factor: 2.631

3.  Estimating ethnic differences in self-reported new use of antidepressant medications: results from the Multi-Ethnic Study of Atherosclerosis.

Authors:  Joseph A C Delaney; Bruce E Oddson; Robyn L McClelland; Bruce M Psaty
Journal:  Pharmacoepidemiol Drug Saf       Date:  2009-07       Impact factor: 2.890

4.  Effects of two stressors on behaviour in the elevated X-maze: preliminary investigation of their interaction with 8-OH-DPAT.

Authors:  J W McBlane; S L Handley
Journal:  Psychopharmacology (Berl)       Date:  1994-10       Impact factor: 4.530

5.  Diagnostic overlap of generalized anxiety disorder and major depressive disorder in a primary care sample.

Authors:  Tomislav D Zbozinek; Raphael D Rose; Kate B Wolitzky-Taylor; Cathy Sherbourne; Greer Sullivan; Murray B Stein; Peter P Roy-Byrne; Michelle G Craske
Journal:  Depress Anxiety       Date:  2012-11-26       Impact factor: 6.505

6.  Symptoms of Anxiety and Depression in Young Athletes Using the Hospital Anxiety and Depression Scale.

Authors:  Stephanie Weber; Christian Puta; Melanie Lesinski; Brunhild Gabriel; Thomas Steidten; Karl-Jürgen Bär; Marco Herbsleb; Urs Granacher; Holger H W Gabriel
Journal:  Front Physiol       Date:  2018-03-07       Impact factor: 4.566

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.